33 results found.
Company Revenue 3Q16: A Final Look
By Julie A. Vetalice As we wrap up orthopaedic revenue for the latest reporting period, we observe that Stryker and Zimmer Biomet lead the largest orthopaedic companies in 3Q16 growth:
Vericel Reports 3Q16 Revenue
Vericel posted 3Q16 Carticel revenue of US $8.3MM, +7.8% vs. 3Q15. Carticel is an autologous chondrocyte implant marketed in the ...
Company Revenue Update, 1H16
By Julie A. Vetalice We complete our coverage of 1H16 revenue in this issue. Stryker and Smith & Nephew lead the top five in growth, with 1H16 performance in the low-single-digits compared to 1H15. DePuy Synthes and Zimmer Biomet reported
Vericel Reports 2Q16 Orthobiologic Revenue
Vericel posted 2Q16 Carticel revenue of US $9.0MM, -1.1% vs. 2Q15, as reported. 
Vericel Posts 1Q16 Orthobiologic Revenue
Vericel posted 1Q16 Carticel revenue of US $8.8MM, +23.9% vs. 1Q15, as-reported.
Vericel Reports 4Q15/2015 Revenue
Vericel reported 4Q15 Carticel® autologous cultured chondrocyte revenue of US $11.3MM, and 2015 revenue of $35.2MM, +...
Vericel Reports 3Q15 Revenue
Vericel reported 3Q15 Carticel® revenue of US $7.7MM, +4% vs. 3Q14.
BARE BONES® - August 12, 2015
Vericel reported 2Q15 Carticel® and Epicel® revenue of US $13.6MM, +31% pro forma vs. 2Q14. (Carticel $9.1MM) (
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group